Award recordCONTRACT

LAKESHORE ISOTOPES

PIID VA24414J3548· VHA· 244-NETWORK CONTRACT OFFICE 4· 6505 · DRUGS AND BIOLOGICALS· FY2015· $242,280 net obligations· UEI UW5HBQN45SS7· PA

Description

IGF::OT::IGF FURNISH RADIOPHARMACEUTICAL DRUGS

First action · last action
2014-10-01 · 2016-03-10
Transactions
3
First transaction's obligation
$617,638
Base + all options value (sum of deltas)
$242,280
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
4
SDVOSB flag on record
No
Parent IDV
VA24414D0448
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$617,638$0Base award · 2014-10-01 · this action $617,638 · running total $617,638Modification P00001 · 2015-09-30 · this action -$375,000 · running total $242,638Modification P00002 · 2016-03-10 · this action -$357 · running total $242,280
  • Base2014-10-01+$617,638= $617,638
  • Mod P000012015-09-30-$375,000= $242,638
  • Mod P000022016-03-10-$357= $242,280
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-10-01+$617,638$617,638IGF::OT::IGF FURNISH RADIOPHARMACEUTICAL DRUGS
Mod P00001· CHANGE ORDER2015-09-30−$375,000$242,638IGF::OT::IGF FURNISH RADIOPHARMACEUTICAL DRUGS
Mod P00002· FUNDING ONLY ACTION2016-03-10−$357$242,280IGF::OT::IGF FURNISH RADIOPHARMACEUTICAL DRUGS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UW5HBQN45SS7)

AwardOffice · PSC / listingNet obligationsFY
36C24420P0044244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$343,443FY2020
VA24417J6392244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$321,980FY2018
VA24417D0369244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$0FY2017
VA24417J0009244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$250,629FY2017
VA24416J5496244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$16,844FY2016
VA24416J5500244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$4,875FY2016

Other recipients under 6505 from 244-NETWORK CONTRACT OFFICE 4 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24416J2870SOFIE CO.244-NETWORK CONTRACT OFFICE 4$69,510FY2016
VA24416D0150SOFIE CO.244-NETWORK CONTRACT OFFICE 4$0FY2016
VA24016E0159MCKESSON CORPORATION244-NETWORK CONTRACT OFFICE 4$15,472,688FY2016
VA24016E0116MCKESSON CORPORATION244-NETWORK CONTRACT OFFICE 4$11,473,859FY2016
VA24416J1948BAXALTA US INC.244-NETWORK CONTRACT OFFICE 4$35,410FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24414J3548_3600_VA24414D0448_3600 · retrieved 2026-09-27.